Since α-GalCer pretreatment increased the IL4-producing iNKT2 cell subset (Figure 1D), we reasoned that OCH pretreatment may confer similar or more enhanced protective effects against sepsis than α-GalCer. This evidence concerns the gene IL4 and Sepsis.